Bot Image

Bot Image’s ProstatID is an AI software product that assists physicians in the interpretation of prostate cancer using MRI and it provides a real-time detection and diagnostic output.

The company developed this software to aid radiologist in the accurate and early detection of prostate cancer given that it is the second leading cause of death in men in the developed world and radiologists often lack the training and expertise to accurately interpret prostate MRI leading to premature deaths and/or misdiagnoses.

Bot Image was founded in 2018 with the mission of using AI combined with advanced imaging modalities to improve healthcare in both cost and accuracy. In this short time, the company has achieved FDA clearance, ISO certification, and significant distribution contracts, and it continues to develop similar detection algorithms for other cancers and abnormalities.